Passa al contenuto
Merck

Vai a

D8446

P7C3

≥98% (HPLC)

Sinonimo/i:

3,6-Dibromo-a-[(phenylamino)methyl]-9H-carbazole-9-ethanol

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Taglio della confezioneSKUDisponibilitàPrezzo
5 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 129.00
CHF 109.65
25 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 475.00

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C21H18Br2N2O
Numero CAS:
Peso molecolare:
474.19
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12352203
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:

CHF 109.65

Prezzo di listinoCHF 129.00Risparmia il 15%
Promozione valida solo online

Per conoscere la disponibilità, visualizza il carrello

Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


Quality Level

assay

≥98% (HPLC)

form

powder

color

white to off-white

solubility

DMSO: 34 mg/mL

storage temp.

2-8°C

SMILES string

OC(CNc1ccccc1)Cn2c3ccc(Br)cc3c4cc(Br)ccc24

InChI

1S/C21H18Br2N2O/c22-14-6-8-20-18(10-14)19-11-15(23)7-9-21(19)25(20)13-17(26)12-24-16-4-2-1-3-5-16/h1-11,17,24,26H,12-13H2

InChI key

FZHHRERIIVOATI-UHFFFAOYSA-N

Application

P7C3 is an aminopropyl carbazole agent with proneurogenic and neuroprotective properties in newborn neural precursor cells of the dentate gyrus. Its analogs may be used in neurodegenerative disease research to study the process of neurogenesis in brain regions such as the subgranular zone of the hippocampal dentate gyrus.[1] P7C3 and its analogs may be used to study its pharmacokinetics, metabolism, safety, efficacy and methods of delivery as potential drug for the treatment of condition such as Alzheimer′s disease, Parkinson′s disease, amyotrophic lateral sclerosis and traumatic brain injury.[2]

Biochem/physiol Actions

P7C3 is a proneurogenic, neuroprotective enhancer of neuron formation.
P7C3 is neurogenic and protects new neurons against apoptosis. These activities may be related to its capacity to protect mitochondrial integrity.

Degeneration of the hippocampus is an early manifestation of Alzheimer′s disease. P7C3 promotes neurogenesis in the subgranular zone of the hippocampal dentate gyrus, the site of normal neurogenesis in adult mammals, making it an important lead compound in development of new Alzheimer′s treatments.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
S7826PZ0111SML0515
P7C3 ≥98% (HPLC)

Sigma-Aldrich

D8446

P7C3

SMER3 ≥98% (HPLC)

Sigma-Aldrich

S7826

SMER3

PD-407824 ≥98% (HPLC)

Sigma-Aldrich

PZ0111

PD-407824

DCAP ≥95% (HPLC)

Sigma-Aldrich

SML0515

DCAP

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥95% (HPLC)

form

powder

form

powder

form

powder

form

powder

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

room temp

solubility

DMSO: 34 mg/mL

solubility

DMSO: ≥30 mg/mL

solubility

DMSO: >10 mg/mL

solubility

DMSO: 5 mg/mL, clear (warmed)

color

white to off-white

color

yellow

color

yellow to orange

color

white to beige


pictograms

Skull and crossbonesCorrosion

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 3 Oral - Eye Dam. 1

Classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



A K Walker et al.
Molecular psychiatry, 20(4), 500-508 (2014-04-23)
Augmenting hippocampal neurogenesis represents a potential new strategy for treating depression. Here we test this possibility by comparing hippocampal neurogenesis in depression-prone ghrelin receptor (Ghsr)-null mice to that in wild-type littermates and by determining the antidepressant efficacy of the P7C3
Hidehiro Oku et al.
Japanese journal of ophthalmology, 61(2), 195-203 (2016-12-30)
To determine whether P7C3-A20, a proneurogenic neuroprotective agent, can protect the retinal ganglion cells (RGCs) of rats from optic nerve crushing. The left optic nerve of 67 rats was crushed, and 5.0 mg/kg/day of P7C3-A20 (crush-P7C3) or its vehicle (crush-placebo) was
Rachel Tesla et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(42), 17016-17021 (2012-10-03)
We previously reported the discovery of P7C3, an aminopropyl carbazole having proneurogenic and neuroprotective properties in newborn neural precursor cells of the hippocampal dentate gyrus. We have further found that chemicals having efficacy in this in vivo screening assay also



Numero articolo commerciale globale

SKUGTIN
D8446-5MG04061833234303
D8446-25MG04061833234297

Questions

Reviews

No rating value

Active Filters